Yuli Qian

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Clinical and translational science

Drug metabolism and disposition: the biological fate of chemicals

Clinical and experimental dermatology

Clinical pharmacology and therapeutics

Celgene Avilomics Research

University of Florida (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Celgene Avilomics Research Jul 20 2015 - Mar 01 2016

United States

Research Associate :: DMPK, Preclinical Division

Education History

University of Florida May 01 2016

United States

PHD :: Pharmacotherapy and Translational Research

Tufts University - Boston Campus Sep 01 2013 - May 17 2015

United States

MSC :: Pharmacology and Drug Development

Hunan University Sep 01 2009 - Jun 01 2013

China

BSC :: Biotechnology

Publications

Stephen Tyring, Angela Moore, Akimchi Morita, H Chih-Ho Hong, In-Ho Song, Jason Eccleston, Gweneth Levy, Mohamed-Eslam F Mohamed, Yuli Qian, Tianshuang Wu, Anqi Pan, Kinjal Hew, Kim A Papp
Cedirogant in adults with psoriasis: a phase 2, randomized, placebo-controlled clinical trial. Clinical and experimental dermatology (2024)
Ryota Kikuchi, Yuli Qian, Mohamed Badawi, John P Savaryn, Shashikanth Gannu, Ann Eldred, Shuai Hao, Ahmed Hamed Salem, Wei Liu, Cheri E Klein, Mohamed-Eslam F Mohamed
Coproporphyrin-I as a Selective OATP1B Biomarker Can Be Used to Delineate the Mechanisms of Complex Drug-Drug Interactions: Cedirogant Case Study. Clinical pharmacology and therapeutics (2024)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Yuli Qian, John S Markowitz
Natural Products as Modulators of CES1 Activity. Drug metabolism and disposition: the biological fate of chemicals 48 (10) (2020)

Yuli Qian.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuli Qian